DexCom, Inc. Reports Third Quarter 2016 Financial Results

Go back to DexCom, Inc. Reports Third Quarter 2016 Financial Results

Leerink Partners Cuts Price Target on DexCom (DXCM) Following 3Q

November 2, 2016 8:29 AM EDT

Leerink Partners maintained an Outperform rating on DexCom (NASDAQ: DXCM), and cut the price target to $100.00 (from $115.00), following the company's 3Q earnings report. DXCM reported revenue of $148.6M, ahead of the Streets $146.6M. Higher OpEx drove EPS below expectations.

Analyst Danielle Antalffy commented, "DXCM shares could underperform today despite a 3Q16 sales beat given: (1) The company... More

DexCom (DXCM) Misses Q3 EPS by 9c

November 1, 2016 4:10 PM EDT

DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.22), $0.09 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $148.6 million versus the consensus estimate of $146.26 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.

... More